Financhill
Back

Sarepta Therapeutics Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
121.65
Seasonality Move:
7.54%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Sarepta Therapeutics Stock Forecast

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 22.8% based on the past 27 years of stock performance.
  • Sarepta Therapeutics has risen higher in 16 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 59.26%
  • Is Sarepta Therapeutics Stock Undervalued?
    The current Sarepta Therapeutics [SRPT] share price is $121.61. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sarepta Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 22.8% based on the past 27 years of stock performance.

Sarepta Therapeutics Stock Rating

Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics overpriced?

  • Sarepta Therapeutics has risen higher in 16 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 59.26%

Sarepta Therapeutics Stock Price History

Is SRPT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com

52-Week Data

52-Week High:
173.25
52-Week Low:
76.25

Prediction Charts

Market Cap:
11.62B
Price in USD:
121.61
Volume:
1.48M
Beta:
1.06

Technical Analysis

SMA50:
126.18
SMA100:
135.36
SMA200:
130.61
52-Wk Change:
50.71%

Stock Predictions

  • Is Sarepta Therapeutics stock public?
    Yes, Sarepta Therapeutics is a publicly traded company.
  • What is the Sarepta Therapeutics stock quote today?
    The Sarepta Therapeutics stock price is 121.61 USD today.
  • How to buy Sarepta Therapeutics stock online?
    You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-22 126.26 128.42 128.54 126.21
Oct-23 131.00 129.88 131.00 126.78
Oct-24 129.90 132.02 132.88 129.53
Oct-25 132.10 131.14 133.36 130.93
Oct-28 131.37 130.26 132.80 129.26
Oct-29 130.07 130.19 131.17 129.26
Oct-30 129.32 127.70 130.86 127.40
Oct-31 127.32 126.00 128.19 125.92
Nov-1 125.91 123.29 126.51 122.68
Nov-4 123.30 123.07 124.03 121.01
Nov-5 123.00 125.01 125.25 121.18
Nov-6 126.50 127.97 128.32 122.45
Nov-7 132.40 120.42 133.00 117.52
Nov-8 120.50 121.61 121.96 116.32

Sarepta Therapeutics Earnings

Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sarepta Therapeutics Forecast Revenue Growth

Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $2.83 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.70 per share, and an increase next year of $8.80 per share.

* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.